Pancreatic Cancer Research

ResearcherFirst Hospital of Jilin UniversityActive in the last 2 years

Feng Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8451-4516; OpenAlex author ID A5101571731. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 3 papers · 2026: 3 papers

Papers 7

  1. TriCON: A Carbon-Based Triple-Modal Nanoplatform for Pancreatic Cancer Therapy. Co-author DOI 10.1002/advs.202512978↗
  2. Arachidonic acid induces pyroptosis via a non-autophagic function of mitophagy and enhances immunotherapy in a PDAC model. Last author DOI 10.1038/s41467-025-68267-2↗
  3. CAV1-DOT1L axis in TAM-derived EVs orchestrates VM and sensitises PDAC to combined VM and VEGF targeting. Last author DOI 10.1136/gutjnl-2025-337293↗
  4. Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study. Co-author DOI 10.1158/1078-0432.ccr-24-4300↗
  5. CircERC1 facilitates chemoresistance through inhibiting pyroptosis and remodeling extracellular matrix in pancreatic cancer. Last author DOI 10.1186/s12943-025-02385-9↗
  6. Hsa_circ_0058495-mediated IGF2BP2 ubiquitination and m6A modification of MEKK1 promote the progression of PDAC. Last author DOI 10.7150/thno.117202↗
  7. Ubiquitin signaling in pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fmolb.2023.1304639↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengnan Lv · 5 shared papers, 2023–2026 · strength 1.19
  2. Tongjia Chu · 4 shared papers, 2025–2026 · strength 1.00
  3. Xinyu Peng · 3 shared papers, 2023–2026 · strength 0.73
  4. Jian Zhang · 2 shared papers, 2023–2025 · strength 0.46
  5. Ziyu Liu · 1 shared paper, 2026 · strength 0.32
  6. Yan Liu · 1 shared paper, 2026 · strength 0.29
  7. Bao‐Lian Su · 1 shared paper, 2026 · strength 0.29
  8. Xiaoya Shi · 1 shared paper, 2025 · strength 0.26
  9. Tiansuo Zhao · 1 shared paper, 2025 · strength 0.26
  10. Lianjing Cao · 1 shared paper, 2025 · strength 0.26
  11. He Ren · 1 shared paper, 2025 · strength 0.26
  12. Jian Zhang · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.